Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 421, doi. 10.1007/s11899-014-0234-1
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2014 AND VI 9 AND IP 4
Results: 15
1
2
An Immune Dysregulation in MPN.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 331, doi. 10.1007/s11899-014-0227-0
- By:
- Publication type:
- Article
3
Lessons from the Atomic Bomb About Secondary MDS.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 407, doi. 10.1007/s11899-014-0235-0
- By:
- Publication type:
- Article
4
Chronic Myelomonocytic Leukemia Prognostic Classification and Management: Evidence Base and Current Practice.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 301, doi. 10.1007/s11899-014-0225-2
- By:
- Publication type:
- Article
5
Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 319, doi. 10.1007/s11899-014-0226-1
- By:
- Publication type:
- Article
6
Epidemiology of MPN: What Do We Know?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 340, doi. 10.1007/s11899-014-0228-z
- By:
- Publication type:
- Article
7
Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 350, doi. 10.1007/s11899-014-0229-y
- By:
- Publication type:
- Article
8
Controversies in Multiple Myeloma: to Transplant or Not?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 360, doi. 10.1007/s11899-014-0230-5
- By:
- Publication type:
- Article
9
Back to Biology: New Insights on Inheritance in Myeloproliferative Disorders.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 311, doi. 10.1007/s11899-014-0232-3
- By:
- Publication type:
- Article
10
I Walk the Other Line: Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 400, doi. 10.1007/s11899-014-0233-2
- By:
- Publication type:
- Article
11
Resuscitating a Dying Marrow: the Role of Hematopoietic Growth Factors.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 412, doi. 10.1007/s11899-014-0236-z
- By:
- Publication type:
- Article
12
I Walk the Line: How to Tell MDS From Other Bone Marrow Failure Conditions.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 389, doi. 10.1007/s11899-014-0224-3
- By:
- Publication type:
- Article
13
Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 368, doi. 10.1007/s11899-014-0237-y
- By:
- Publication type:
- Article
14
What We Mean When We Talk About MRD in Myeloma. A Review of Current Methods. Part 1 of a Two-Part Series.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 379, doi. 10.1007/s11899-014-0238-x
- By:
- Publication type:
- Article
15
Quality of Life in MPN Comes of Age as a Therapeutic Target.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 324, doi. 10.1007/s11899-014-0239-9
- By:
- Publication type:
- Article